Searched for
INDIAN PHARMACEUTICAL COMPANIES
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Hikal commissions cGMP pilot plant in Pune to strengthen pharmaceutical developmentHikal has commissioned an enhanced cGMP pilot plant at its Pune campus to strengthen its integrated capabilities for pharmaceutical develop...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- ICMR licenses cancer, vaccine technologies to Emcure, Biological EThe Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment an...
- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
- Stocks in news: CDSL, Adani Energy, L&T, Adani Total Gas, Emcure PharmaMarkets declined on Monday due to disappointing earnings and geopolitical worries. CDSL faced a Rs 1 crore penalty from Sebi for cybersecur...
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
- Inside the labour supply chain fueling illegal Bangladeshi infiltrationIllegal immigrants from Bangladesh enter India through a planned labor supply chain. Agents facilitate border crossings and transportation ...
- India, Spain to fast-track UPI-Bizum interoperability talksThe two countries have also discussed ways to strengthen investment facilitation, improving mobility of professionals and promoting joint i...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Warburg Pincus buys Mumbai’s pharma company Integrace in Rs 1,200 crore dealIn a landmark transaction, Warburg Pincus, a prominent US private equity firm, has purchased Integrace Private Limited for ₹1,200 crore. Wi...
- First India-UK CETA export consignments flagged off from HyderabadIndia and the United Kingdom launched their comprehensive economic and trade agreement. First export consignments from Hyderabad to the UK ...
- Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one yearFredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify....
- Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman SachsIndian pharmaceutical firms anticipate revenue increases in the first quarter of fiscal year twenty twenty six twenty seven. Profitability ...
Load More
